Cavu Management, LP, 10% Owner at Lantern Pharma Inc. (LTRN), sold 567,425 shares at $4.40 ($2.5M) on 2022-11-08, disclosed to the SEC on 2022-11-09.
Open-market sale of $2.5M LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.40 | 17,748 | $78K | 3.1% |
| 2 | $4.40 | 17,748 | $78K | 3.1% |
| 3 | $4.40 | 40,586 | $179K | 7.2% |
| 4 | $4.40 | 40,586 | $179K | 7.2% |
| 5 | $4.40 | 58,711 | $258K | 10.3% |
| 6 | $4.40 | 58,711 |
| $258K |
| 10.3% |
| 7 | $4.40 | 100,380 | $442K | 17.7% |
| 8 | $4.40 | 100,380 | $442K | 17.7% |
| 9 | $4.40 | 132,575 | $583K | 23.4% |
| Total | $4.40 avg | 567,425 | $2.5M | 100% |
| Filing → |
| INAB | BUY | 2022-08-18 | $170K | — | Filing → |